These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9699648

  • 1. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
    Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF.
    Cancer Res; 1998 Aug 01; 58(15):3237-42. PubMed ID: 9699648
    [Abstract] [Full Text] [Related]

  • 2. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA, de Foy KA, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, Stratton MR, Ponder BA, Barnes D, Eeles RA.
    Cancer Res; 2000 Aug 15; 60(16):4513-8. PubMed ID: 10969800
    [Abstract] [Full Text] [Related]

  • 3. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.
    Cancer Res; 2003 Jan 15; 63(2):342-7. PubMed ID: 12543786
    [Abstract] [Full Text] [Related]

  • 4. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC.
    Cancer Res; 2000 Feb 15; 60(4):1062-9. PubMed ID: 10706125
    [Abstract] [Full Text] [Related]

  • 5. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.
    Bell DW, Erban J, Sgroi DC, Haber DA.
    Cancer Res; 2002 May 15; 62(10):2741-3. PubMed ID: 12019146
    [Abstract] [Full Text] [Related]

  • 6. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.
    Annab LA, Terry L, Cable PL, Brady J, Stampfer MR, Barrett JC, Afshari CA.
    Gynecol Oncol; 2000 Apr 15; 77(1):121-8. PubMed ID: 10739701
    [Abstract] [Full Text] [Related]

  • 7. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T.
    Ann Acad Med Stetin; 2003 Apr 15; 49():27-43. PubMed ID: 15552838
    [Abstract] [Full Text] [Related]

  • 8. BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.
    Lavie O, Hornreich G, Ben-Arie A, Rennert G, Cohen Y, Keidar R, Sagi S, Lahad EL, Auslander R, Beller U.
    Gynecol Oncol; 2004 Feb 15; 92(2):521-4. PubMed ID: 14766242
    [Abstract] [Full Text] [Related]

  • 9. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
    Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M.
    Cancer Res; 2006 Jan 01; 66(1):41-5. PubMed ID: 16397213
    [Abstract] [Full Text] [Related]

  • 10. Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.
    Foulkes WD, Wong N, Brunet JS, Bégin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2465-9. PubMed ID: 9815648
    [Abstract] [Full Text] [Related]

  • 11. [Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].
    Zhou YZ, Sun Q, Lin SQ, Wang J, Liu B, Li JX, Zhou YD, Ye J, Han H, Fang FD.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):294-8. PubMed ID: 15059511
    [Abstract] [Full Text] [Related]

  • 12. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient.
    Randall TC, Bell KA, Rebane BA, Rubin SC, Boyd J.
    Gynecol Oncol; 1998 Sep 17; 70(3):432-4. PubMed ID: 9790802
    [Abstract] [Full Text] [Related]

  • 13. BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.
    Ginolhac SM, Gad S, Corbex M, Bressac-De-Paillerets B, Chompret A, Bignon YJ, Peyrat JP, Fournier J, Lasset C, Giraud S, Muller D, Fricker JP, Hardouin A, Berthet P, Maugard C, Nogues C, Lidereau R, Longy M, Olschwang S, Toulas C, Guimbaud R, Yannoukakos D, Szabo C, Durocher F, Moisan AM, Simard J, Mazoyer S, Lynch HT, Goldgar D, Stoppa-Lyonnet D, Lenoir GM, Sinilnikova OM.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 17; 12(2):90-5. PubMed ID: 12582017
    [Abstract] [Full Text] [Related]

  • 14. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS.
    Clin Cancer Res; 1995 May 17; 1(5):539-44. PubMed ID: 9816013
    [Abstract] [Full Text] [Related]

  • 15. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.
    Hum Mutat; 2005 Mar 17; 25(3):319. PubMed ID: 15712267
    [Abstract] [Full Text] [Related]

  • 16. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry.
    Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, Andrulis IL, O'Malley FP.
    Cancer; 2002 Nov 15; 95(10):2068-75. PubMed ID: 12412159
    [Abstract] [Full Text] [Related]

  • 17. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.
    BMC Cancer; 2006 Sep 29; 6():230. PubMed ID: 17010193
    [Abstract] [Full Text] [Related]

  • 18. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
    Biron-Shental T, Drucker L, Altaras M, Bernheim J, Fishman A.
    Eur J Surg Oncol; 2006 Dec 29; 32(10):1097-100. PubMed ID: 16650962
    [Abstract] [Full Text] [Related]

  • 19. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R, Hussain I, Afroze D, Aejazaziz S, Jan M, Shah ZA, Das BC, Siddiqi MA.
    Cancer Lett; 2007 Apr 18; 248(2):308-20. PubMed ID: 16996204
    [Abstract] [Full Text] [Related]

  • 20. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2009 May 18; 115(1):51-5. PubMed ID: 18483852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.